経口投与可能なテロメアG-四重複リガンドは,テロメア危機を誘導し,がん治療のためのダブルDNA/RNAセンシング先天免疫を誘導する
Jiong-Heng Cai1, Yao-Hui Shi1, Dan-Yan Yang1
1School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China.
Journal of medicinal chemistry
|February 13, 2026
まとめ
CA11は,新しいG-四重複連結体であり,テロメア危機を誘発し,先天的免疫を活性化することによって,癌細胞死を誘発します. この経口生物学的利用可能な薬は,免疫反応を強化し,腫瘍の成長を抑制することによって,がん治療の有望性を示しています.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- 免疫学 免疫学とは
背景:
- テロメア危機は,がん細胞の増殖を阻む重要な障壁である.
- cGAS-STINGとTERRA-ZBP1経路は,それぞれDNAとRNAを感知し,治療標的を提供することに関与しています.
- テロメアをターゲットにすることで,有望な抗がん戦略を提示しています.
研究 の 目的:
- ガン治療のためのテロメア危機を誘発する新しい化合物を発見し,特徴づけること.
- CA11の作用機構を調査するために,G-四重複のリガンドである.
- 臨床前がんモデルにおけるCA11の有効性と安全性を評価する.
主な方法:
- CA11を特定するためのG-クアドルプレックスに焦点を当てたスクリーニングプラットフォーム.
- CA11を用いたテロメアG4sの薬理学的安定化.
- テロメア危機型のフェノタイプと先天性免疫経路の活性化 (DNA/RNAセンシング) の評価.
- 癌細胞系における抗増殖効果と腫瘍成長抑制の評価 in vivo.
- システム性耐受性の評価. システム性耐受性の評価.
主要な成果:
- 経口生物利用可能なキナゾリン誘導体CA11が特定されました.
- CA11はテロメアG4sを安定させ,テロメア危機のようなフェノタイプを誘発する.
- 双重DNA/RNAセンサーの先天性免疫経路の調整された活性化が観察されました.
- CA11は広範な抗増殖効果を示し,腫瘍の成長を vivo で抑制しました.
- CA11は,全身的に良好に耐えた.
結論:
- CA11は,口服で活性化されるテロメリックG4リガンドで,クラスで初めてです.
- CA11は薬理学的にテロメア危機を誘発し,先天免疫とオートファギーを活性化します.
- CA11は強力な抗がん活性を示しており,がん治療の有望な候補である.
関連する概念動画
02:41Telomeres and Telomerase
27.4K
In eukaryotic DNA replication, a single-stranded DNA fragment remains at the end of a chromosome after the removal of the final primer. This section of DNA cannot be replicated in the same manner as the rest of the strand because there is no 3’ end to which the newly synthesized DNA can attach. This non-replicated fragment results in gradual loss of the chromosomal DNA during each cell duplication. Additionally, it can induce a DNA damage response by enzymes that recognize single-stranded...
27.4K
02:41Telomeres and Telomerase
7.4K
7.4K
01:21Introduction to Innate and Adaptive Immunity
10.0K
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
10.0K
01:28Cells of the Innate Immune Response
9.5K
The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
9.5K
02:49Cancer Therapies
10.2K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.2K
00:49Ligand Binding and Linkage
5.6K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K